-
公开(公告)号:US20180353644A1
公开(公告)日:2018-12-13
申请号:US16108581
申请日:2018-08-22
申请人: LifeCell Corporation
发明人: Wenquan Sun , Melissa Richter Bowley , Goel Raghav
IPC分类号: A61L27/24 , A61K35/545 , A61K38/19 , A61K38/18 , A61K35/35 , A61L27/36 , A61L27/54 , A61L27/38 , A61L27/26 , A61L27/20
CPC分类号: A61L27/24 , A61F2/02 , A61K35/35 , A61K35/545 , A61K38/18 , A61K38/19 , A61L2/081 , A61L2/087 , A61L2/206 , A61L27/20 , A61L27/26 , A61L27/362 , A61L27/3687 , A61L27/3691 , A61L27/3834 , A61L27/54 , A61L27/56 , A61L2430/34 , C08L5/02
摘要: Methods of making tissue fillers are provided. In certain embodiments, the tissue is flake-like and has regenerative properties.
-
公开(公告)号:US10137224B2
公开(公告)日:2018-11-27
申请号:US14698763
申请日:2015-04-28
IPC分类号: A61L27/36 , A61K35/12 , A61K35/35 , C12N5/077 , A61K35/28 , A61L27/54 , A61L27/56 , A61L27/38
摘要: Disclosed are products and methods for treating soft tissue injuries. The provided methods include the production of processed or cryopreserved microvascular tissue. Also provided are products and methods of using processed or cryopreserved microvascular tissue for the treatment of soft tissue injuries.
-
公开(公告)号:US10092677B2
公开(公告)日:2018-10-09
申请号:US15344855
申请日:2016-11-07
申请人: LifeCell Corporation
发明人: Hui Xu , Wenquan Sun , Hua Wan , Rick T. Owens
IPC分类号: A61K35/35 , A61K31/728 , A61K38/18 , A61L27/36 , A61K38/17 , A61L27/20 , A61L27/54 , C08L5/08 , A61L27/34 , A61L27/22
摘要: Tissue fillers derived from decellularized tissues are provided. The tissue fillers can include acellular tissue matrices that have reduced inflammatory responses when implanted in a body. Also provided are methods of making and therapeutic uses for the tissue fillers.
-
公开(公告)号:US10092598B2
公开(公告)日:2018-10-09
申请号:US15044498
申请日:2016-02-16
申请人: RegenLab USA LLC
IPC分类号: A61L24/00 , A61L24/10 , A61L26/00 , A61M1/36 , A61K35/14 , A61K35/16 , A61K38/18 , A61K35/18 , A61K35/36 , A61Q19/00 , A61K8/98 , A61K35/19 , A61K38/36 , A61K35/15 , A61K35/28 , A61K35/30 , A61K35/32 , A61K35/34 , A61K35/35 , A61K35/38 , A61K35/39 , A61K35/51 , A61K38/48 , A61L27/36 , A61L27/38 , A61Q19/08
摘要: The present invention relates to new plasma or new platelet-rich plasma preparations, new cell dissociation methods, new cell associations or compositions, a method of preparation thereof, a use thereof, devices for the preparation thereof and preparations containing such a platelet-rich plasma preparation and cell associations or compositions. Specifically, the invention provides plasma or platelet-rich plasma alone or in cell combinasons preparations for use in tissue regeneration and bone regeneration and pain reduction.
-
公开(公告)号:US10085963B2
公开(公告)日:2018-10-02
申请号:US14936830
申请日:2015-11-10
申请人: SAMI LABS LIMITED
IPC分类号: A61K31/352 , A61K35/35 , C12N5/077 , G01N33/50
摘要: Disclosed is a method of achieving optimal mammalian energy balance using forskolin on a particular physiological and developmental stage of the mammalian cellular system.
-
公开(公告)号:US20180216070A1
公开(公告)日:2018-08-02
申请号:US15743062
申请日:2016-07-08
申请人: ETABLISSEMENT FRANCAIS DU SANG , INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE , UNIVERSITE TOULOUSE III - PAUL SABATIER , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
发明人: FREDERIC DESCHASEAUX , FABIEN GUILLOTON , SANDRA MULLER , LUC SENSEBE , LOUIS CASTEILLA , AUDREY CARRIERE-PAZAT
CPC分类号: C12N5/0653 , A61K35/35 , C12N5/0663 , C12N5/0667 , C12N2501/105 , C12N2501/11 , C12N2501/115 , C12N2501/155 , C12N2501/165 , C12N2501/33 , C12N2501/999 , C12N2502/115 , C12N2506/13 , C12N2506/1346 , C12N2513/00 , G01N33/50 , G01N33/5044
摘要: The present invention concerns a method of producing brown/beige adipocytes from white adipose tissue cells and/or mesenchymal stem cells, in particular from subcutaneous white adipose tissue cells, and the use of said brown/beige adipocytes in a cell based therapy of a subject or in screening platforms.
-
公开(公告)号:US10017740B2
公开(公告)日:2018-07-10
申请号:US14664441
申请日:2015-03-20
申请人: PLASTICELL LIMITED
发明人: Marina Tarunina , Yen Choo , Mylvaganam Jeyakumar , Thomas Watson , Meritxell Rosell , Lilian Hook , Diana Hernandez
CPC分类号: C12N5/0653 , A61K35/35 , C12N2500/24 , C12N2500/25 , C12N2501/01 , C12N2501/04 , C12N2501/155 , C12N2501/33 , C12N2502/1352 , C12N2506/1384
摘要: The present invention relates to brown adipose tissue (BAT) cells derived from adult stern or progenitor cells, derived from adult white fat tissue (WAT), as well as to methods for deriving such cells.
-
公开(公告)号:US20180147241A1
公开(公告)日:2018-05-31
申请号:US15877803
申请日:2018-01-23
发明人: Robert G Matheny
IPC分类号: A61K35/35 , A61K35/12 , A61K38/18 , A61K45/06 , A61K48/00 , A61L27/36 , A61L27/38 , A61L27/54 , A61M1/12
CPC分类号: A61K35/35 , A61K35/12 , A61K35/28 , A61K35/34 , A61K35/44 , A61K38/18 , A61K38/1808 , A61K38/1841 , A61K38/185 , A61K38/1866 , A61K45/06 , A61K48/00 , A61L27/3604 , A61L27/3629 , A61L27/3633 , A61L27/367 , A61L27/3826 , A61L27/3834 , A61L27/54 , A61L2300/414 , A61L2300/434 , A61L2300/64 , A61L2430/20 , A61M1/122 , A61M2205/05 , A61P9/10
摘要: Methods for treating cardiovascular disorders that include administration of an ECM based composition to damaged cardiovascular tissue in conjunction with a treatment remedy, such as ventricular assistance and transmyocardial revascularization (TMR), which induces enhanced bioremodeling of the damaged cardiovascular tissue and regeneration of new cardiovascular tissue and associated structures with site-specific structural and functional properties.
-
69.
公开(公告)号:US20180133366A1
公开(公告)日:2018-05-17
申请号:US15814247
申请日:2017-11-15
申请人: Neil RIORDAN
发明人: Neil RIORDAN
IPC分类号: A61L27/36 , A61L27/50 , A61L27/38 , A61K35/39 , A61K35/407 , A61K35/35 , A61K35/50 , A61K35/51 , A61K9/00
CPC分类号: A61L27/3687 , A01N1/021 , A61K9/0019 , A61K35/35 , A61K35/39 , A61K35/407 , A61K35/50 , A61K35/51 , A61L27/3604 , A61L27/3691 , A61L27/3804 , A61L27/50 , A61L2300/214 , A61L2300/232 , A61L2300/406 , A61L2400/06
摘要: Disclosed are compositions of matter, protocols, and treatment means for generation of tissues capable of administration in a flowable manner through contain with one or more antibiotics, or derivatives of said antibiotics. In one embodiment the invention provides the treatment of morselized amniotic membranes with antibiotics in a manner as to increase buoyancy of morselized components of said amniotic membranes in order to prevent gravity based accumulation of said morselized tissue. In another embodiment buoyancy of morselized tissue is modulated by contacting said tissue with an antibiotic or derivative thereof in a manner to allow for increased uniformity of said morselized tissue components throughout a vessel. In another embodiment, pancreatic islets are isolated and stored in a manner to prevent gravity based aggregation. The invention pertains to all tissues, with emphasize in a preferred embodiment to tissues which are useful when administered in a flowable manner.
-
公开(公告)号:US09950014B2
公开(公告)日:2018-04-24
申请号:US14425960
申请日:2013-08-31
申请人: Pluristem Ltd.
发明人: Ayelet Chajut , Eytan Abraham
CPC分类号: A61K35/35 , A61K35/28 , A61K35/50 , C12N5/0605 , C12N5/0653 , C12N2513/00
摘要: Methods for treating or preventing preeclampsia or eclampsia by administering adherent stromal cells are described. The adherent stromal cells may be derived from bone marrow, placenta, or adipose tissue. Also described is the use of adherent stromal cells for the manufacture of a medicament, and an article of manufacture comprising a packaging material which comprises a label for use in treating or preventing preeclampsia or eclampsia.
-
-
-
-
-
-
-
-
-